Limba
Romanian
Romanian
English|
Sirpiglenastat (DRP-104) is a broad acting glutamineantagonist. It has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response with immunomodulatory and antineoplastic activities.
| Price | 9.875,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Sirpiglenastat (DRP-104) is a broad acting glutamineantagonist. It has anticancer effects by directly targeting tumor metabolism and simultaneously inducing a potent antitumor immune response with immunomodulatory and antineoplastic activities. |
